Cita APA

M.T., J., G., P., B., S., L., C., J., J., C., P., . . . N., A. (2021). Atherogenic dyslipidemia, but not hyperglycemia, is an independent factor associated with liver fibrosis in subjects with type 2 diabetes and NAFLD: A population-based study.

Citación estilo Chicago

M.T., Julián, et al. Atherogenic Dyslipidemia, but Not Hyperglycemia, Is an Independent Factor Associated With Liver Fibrosis in Subjects With Type 2 Diabetes and NAFLD: A Population-based Study. 2021.

Cita MLA

M.T., Julián, et al. Atherogenic Dyslipidemia, but Not Hyperglycemia, Is an Independent Factor Associated With Liver Fibrosis in Subjects With Type 2 Diabetes and NAFLD: A Population-based Study. 2021.